<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Ventilator-induced lung injury</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Ventilator-induced lung injury</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Ventilator-induced lung injury</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert C Hyzy, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Polly E Parsons, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Geraldine Finlay, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 17, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Lung injury can be an adverse consequence of mechanical ventilation. This injury is called ventilator-induced lung injury (VILI) and can result in pulmonary edema, barotrauma, and worsening hypoxemia that can prolong mechanical ventilation, lead to multi-system organ dysfunction, and increase mortality. Thus, adopting a ventilator strategy that reduces VILI is an important goal in ventilatory management.</p><p>The incidence, mechanisms, diagnostic evaluation, and management of VILI are discussed in this topic review. Other consequences of mechanical ventilation and the diagnosis and management of barotrauma are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1628.html" rel="external">"Clinical and physiologic complications of mechanical ventilation: Overview"</a> and  <a class="medical medical_review" href="/z/d/html/1592.html" rel="external">"Diagnosis, management, and prevention of pulmonary barotrauma during invasive mechanical ventilation in adults"</a>.)</p><p class="headingAnchor" id="H1645080884"><span class="h1">DEFINITIONS (VILI, VALI, SILI)</span><span class="headingEndMark"> — </span>VILI, ventilator-associated lung injury (VALI), and self-induced lung injury (SILI) are defined below. Barotrauma is a form of VILI that is associated with alveolar rupture due to elevated transalveolar pressure; this form of VILI is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1592.html" rel="external">"Diagnosis, management, and prevention of pulmonary barotrauma during invasive mechanical ventilation in adults", section on 'Definition'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>VILI – VILI is an acute lung injury affecting the airways and parenchyma that is caused by or exacerbated by mechanical ventilation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>VALI – In clinical practice, it is often difficult to determine if the lung injury that a patient has developed was caused by the ventilatory pattern or was due to the patient's worsening underlying lung condition. As such, the term VALI is often used if a causative relationship between lung injury and the mechanical ventilator cannot be proven [<a href="#rid1">1</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>SILI – Excessive tidal volume generated by spontaneous efforts can also cause lung injury [<a href="#rid2">2</a>].</p><p></p><p>Some experts propose the terms ventilation-induced or -associated lung injury as a more global way to define injury due to overdistension of the lung or alveolar stretch.</p><p>Many experts consider VILI as the "process" of injury while VALI is the end result (ie, the condition). However, despite different definitions, the terms are often used interchangeably.</p><p class="headingAnchor" id="H77257600"><span class="h1">INCIDENCE AND RISK FACTORS</span><span class="headingEndMark"> — </span>VILI is mostly seen in patients ventilated for acute respiratory distress syndrome (ARDS) but over the past few years, it has become clear that it also occurs in patients ventilated for reasons other than ARDS.</p><p class="bulletIndent1"><span class="glyph">●</span>ARDS patients – Because the manifestations of VILI are virtually indistinguishable from ARDS, the true incidence is unknown but presumed to be higher than in patients without ARDS. Patients with ARDS are at risk of further lung injury because the lung is already injured ("primed"). In addition, the underlying pathophysiology of ARDS predisposes the lung to further injury from overdistension (because large portions of the lung are unavailable for ventilation) and from atelectrauma. (See <a class="local">'Mechanisms'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Non-ARDS patients – The incidence of VILI in ventilated non-ARDS patients is also unknown. In an observational study of 332 mechanically ventilated patients who were intubated for non-ARDS causes [<a href="#rid3">3</a>], risk factors for subsequent VILI included high tidal volumes (&gt;6 mL per kg of predicted body weight), blood product transfusions, acidemia (pH &lt;7.35), and restrictive lung disease [<a href="#rid3">3</a>]. It is probable that similar risk factors exist in patients with ARDS.</p><p></p><p>It is thought that genetic variations place patients at increased risk for lung injury, although none are currently used as markers or therapeutic targets [<a href="#rid4">4-8</a>].</p><p class="headingAnchor" id="H2"><span class="h1">MECHANISMS</span><span class="headingEndMark"> — </span>Alveolar overdistension, atelectrauma, and biotrauma are the principal mechanisms of VILI during mechanical ventilation, although the relative importance of each mechanism is unknown [<a href="#rid9">9,10</a>]. Alveolar injury results in high alveolar permeability, interstitial and alveolar edema, alveolar hemorrhage, hyaline membranes, loss of functional surfactant, and alveolar collapse (ie, findings similar to those observed in acute respiratory distress syndrome [ARDS]) [<a href="#rid1">1,10,11</a>].</p><p class="headingAnchor" id="H3"><span class="h2">Alveolar overdistension (volutrauma)</span><span class="headingEndMark"> — </span>Volutrauma represents lung injury caused as lung units are overdistended with increased transpulmonary pressure [<a href="#rid12">12</a>]. Animal studies have demonstrated that high tidal volumes (or high lung volumes), rather than high airway pressure per se, cause lung injury  (<a class="graphic graphic_figure graphicRef69085" href="/z/d/graphic/69085.html" rel="external">figure 1</a> and <a class="graphic graphic_figure graphicRef69228" href="/z/d/graphic/69228.html" rel="external">figure 2</a>) [<a href="#rid13">13,14</a>]. In patients intubated for reasons other than ARDS, overdistension from high tidal volumes has also been shown to increase the risk for VILI (odds ratio 1.3, 95% CI 1.12-1.51, for each mL above 6 mL per kg of ideal body weight) [<a href="#rid3">3</a>]. In addition, avoiding overdistension by using low tidal volume strategies is beneficial in patients with ARDS, the details of which are provided separately. (See  <a class="medical medical_review" href="/z/d/html/1653.html" rel="external">"Acute respiratory distress syndrome: Ventilator management strategies for adults", section on 'Low tidal volume ventilation: Initial settings'</a>.)</p><p>Large tidal volumes are not always required for alveolar overdistension. When there is heterogeneous consolidation or atelectasis (eg, patient with ARDS), a disproportionate volume from each breath is delivered to the open alveoli. This can cause regional alveolar overdistension and VILI despite delivery of conventional tidal volumes that are based upon body weight [<a href="#rid15">15</a>]. A similar process is at play when lung compliance is reduced such as severe fibrosis or during single lung ventilation when a tidal breath is distributed to only one lung as opposed to two.</p><p class="headingAnchor" id="H4"><span class="h2">Atelectrauma</span><span class="headingEndMark"> — </span>Animal models have demonstrated that cyclic alveolar expansion (during inspiration) and collapse (during expiration) creates shear forces that distend and cause injury to adjacent alveoli and airways  (<a class="graphic graphic_figure graphicRef52485" href="/z/d/graphic/52485.html" rel="external">figure 3</a>) [<a href="#rid16">16-18</a>]. Specifically, non-atelectatic alveoli are exposed to the injurious impact of neighboring atelectatic alveoli that are opening and collapsing during tidal breathing. This process is referred to as cyclical atelectasis, or atelectrauma. Surfactant depletion or dysfunction may play a role in atelectrauma [<a href="#rid19">19</a>]. Strategies aimed at limiting atelectrauma (eg, high positive end-expiratory pressure and open lung ventilation) have had mixed effects in human trials and are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1653.html" rel="external">"Acute respiratory distress syndrome: Ventilator management strategies for adults", section on 'Open lung ventilation'</a>.)</p><p class="headingAnchor" id="H3825445484"><span class="h2">Biotrauma (inflammation)</span><span class="headingEndMark"> — </span>Biotrauma is characterized by ventilator-induced release of inflammatory mediators from cells within the injured lung [<a href="#rid20">20-22</a>]. Both alveolar overdistension and atelectrauma have been shown in animals to result in an increase in inflammatory mediators (from neutrophils, macrophages, and likely alveolar epithelial cells) including tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, IL-8, matrix metalloproteinase-9, and transcription factor nuclear factor (NF)-kB [<a href="#rid23">23-26</a>]. In patients with ARDS, similar inflammatory mediators are elevated and several randomized trials that show a mortality benefit to low tidal volume ventilation (LTVV), also report a concurrent reduction in lavage and serum cytokines with LTVV strategies [<a href="#rid27">27,28</a>]. Another study demonstrated that the changes in serum cytokine levels can occur within one hour of a change in ventilatory strategy, suggesting that even relatively short periods of injurious ventilation may be deleterious [<a href="#rid29">29-31</a>]. There is also evidence that injurious ventilatory strategies may lead to the subsequent development of pulmonary fibrosis (in animals) [<a href="#rid32">32</a>] and to the development of multi-organ failure (in humans) [<a href="#rid33">33,34</a>], although the precise mechanisms are unclear. However, many of the strategies that target inflammation in ARDS/VILI have not been successful, although corticosteroids may be of value in select circumstances. (See  <a class="medical medical_review" href="/z/d/html/1653.html" rel="external">"Acute respiratory distress syndrome: Ventilator management strategies for adults", section on 'Low tidal volume ventilation: Initial settings'</a> and  <a class="medical medical_review" href="/z/d/html/1618.html" rel="external">"Acute respiratory distress syndrome: Investigational or ineffective therapies in adults", section on 'Anti-inflammatory therapies'</a> and  <a class="medical medical_review" href="/z/d/html/1641.html" rel="external">"Acute respiratory distress syndrome: Fluid management, pharmacotherapy, and supportive care in adults", section on 'Glucocorticoids'</a>.)</p><p class="headingAnchor" id="H702986142"><span class="h1">CLINICAL FEATURES AND DIAGNOSTIC EVALUATION</span><span class="headingEndMark"> — </span>The clinical presentation and diagnostic evaluation of patients with ventilator-associated lung injury (VALI) is similar to patients with progressive acute respiratory distress syndrome (ARDS) with the major difference being that the features develop while on mechanical ventilation itself. (See  <a class="medical medical_review" href="/z/d/html/1637.html" rel="external">"Acute respiratory distress syndrome: Clinical features, diagnosis, and complications in adults"</a>.)</p><p class="headingAnchor" id="H910120748"><span class="h2">Clinical presentation</span><span class="headingEndMark"> — </span>While on mechanical ventilation, patients typically develop worsening hypoxemia or require a greater fraction of inspired oxygen (FiO<sub>2</sub>) to maintain the same arterial oxygen tension (PaO<sub>2</sub>) or arterial oxyhemoglobin saturation (SaO<sub>2</sub>). Patients become more tachypneic and tachycardic. The chest radiograph typically shows new or increased bilateral interstitial or alveolar opacities of any severity  (<a class="graphic graphic_diagnosticimage graphicRef53014" href="/z/d/graphic/53014.html" rel="external">image 1</a>). Computed tomography (CT) of the chest demonstrates heterogeneous consolidation and atelectasis, as well as focal hyperlucent areas that represent overdistended lung  (<a class="graphic graphic_diagnosticimage graphicRef71931" href="/z/d/graphic/71931.html" rel="external">image 2</a>). VALI may also be associated with new organ failure [<a href="#rid35">35</a>]. (See  <a class="medical medical_review" href="/z/d/html/1637.html" rel="external">"Acute respiratory distress syndrome: Clinical features, diagnosis, and complications in adults", section on 'Clinical features'</a>.)</p><p class="headingAnchor" id="H3961670384"><span class="h2">Diagnostic evaluation</span><span class="headingEndMark"> — </span>VALI is a clinical diagnosis based upon the features described above (see <a class="local">'Clinical presentation'</a> above) and the exclusion of alternative causes of respiratory deterioration and/or ARDS  (<a class="graphic graphic_table graphicRef58759" href="/z/d/graphic/58759.html" rel="external">table 1</a>) in mechanically ventilated patients. The approach is similar to that in patients with suspected ARDS (see  <a class="medical medical_review" href="/z/d/html/1637.html" rel="external">"Acute respiratory distress syndrome: Clinical features, diagnosis, and complications in adults"</a>). However, there are some features that are different, the details of which are discussed in this section.</p><p>New pulmonary infection and pulmonary edema are the most common etiologies that need to be excluded. However, additional etiologies that occur as a consequence of being critically ill or mechanically ventilated also need to be considered; these include sepsis, aspiration, barotrauma, auto-positive end-expiratory pressure (auto-PEEP), drug or transfusion reactions, venous, fat, air, or amniotic fluid embolism, intra-abdominal distension, endotracheal tube displacement, lobar collapse, pleural effusion, and acute coronary syndromes. We suggest the following general approach:</p><p class="bulletIndent1"><span class="glyph">●</span>Patients should be re-examined for evidence of infection, bronchoconstriction, fluid overload (eg, crackles, edema, elevated jugular venous pulse), barotrauma (eg, unilateral reduced air entry, crepitus), venous thrombosis (lower extremity swelling or erythema), or abdominal hypertension limiting respiration (tense abdomen, ileus). (See  <a class="medical medical_review" href="/z/d/html/1633.html" rel="external">"Assessment of respiratory distress in the mechanically ventilated patient"</a> and  <a class="medical medical_review" href="/z/d/html/2889.html" rel="external">"Abdominal compartment syndrome in adults", section on 'Clinical presentation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A drug history (allergy or drug reaction) and blood product transfusion history (eg, pulmonary edema or transfusion-related lung injury) should be obtained. (See  <a class="medical medical_review" href="/z/d/html/7926.html" rel="external">"Transfusion-related acute lung injury (TRALI)"</a> and  <a class="medical medical_review" href="/z/d/html/95132.html" rel="external">"Approach to the patient with a suspected acute transfusion reaction"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Ventilator settings should be assessed for tidal volume settings &gt;6 mL/kg/min and the presence of auto-PEEP, high peak and plateau pressures (although high peak pressures can occur in the context of increased airway resistance, and high plateau pressures can also be due to a stiff chest wall). Ventilator equipment should also be examined for faulty expiratory valves and heat moisture exchangers. (See  <a class="medical medical_review" href="/z/d/html/1592.html" rel="external">"Diagnosis, management, and prevention of pulmonary barotrauma during invasive mechanical ventilation in adults", section on 'Barotrauma diagnosis and management'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients should also undergo routine laboratory testing (including lipase, coagulation studies, cardiac enzymes), arterial blood gas analysis, chest radiography (eg, new infiltrates, lobar collapse, mainstem intubation, pneumothorax, pleural effusion), and electrocardiography (ST segment changes, new rhythm disturbance).</p><p></p><p>Most etiologies should be identified with initial testing. Further testing should be targeted at the suspected etiology and may include computed tomography (CT) chest, blood and other body fluids culture, echocardiography, lower extremity Doppler studies, and rarely CT pulmonary angiography, bronchoscopy, or lung biopsy. Pulmonary artery catheterization is almost never required unless volume status is unclear. (See  <a class="medical medical_review" href="/z/d/html/1593.html" rel="external">"Pulmonary artery catheterization: Indications, contraindications, and complications in adults", section on 'Indications'</a>.)</p><p class="headingAnchor" id="H7"><span class="h1">PREVENTION AND MANAGEMENT</span><span class="headingEndMark"> — </span>VILI is often an iatrogenic disease; its prevention in ventilated patients is critical. For patients with suspected ventilator-associated lung injury (VALI), we adjust ventilator settings to follow lung protective ventilation used in patients with acute respiratory distress syndrome (ARDS) to prevent further lung injury. (See  <a class="medical medical_review" href="/z/d/html/1653.html" rel="external">"Acute respiratory distress syndrome: Ventilator management strategies for adults", section on 'Low tidal volume ventilation: Initial settings'</a>.)</p><p class="headingAnchor" id="H2811970552"><span class="h2">First line strategies</span><span class="headingEndMark"> — </span>The prevention and management of VALI is the same as for patients with ARDS.</p><p class="bulletIndent1"><span class="glyph">●</span>Patients with ARDS – In patients with ARDS, alveolar overdistension is mitigated (but not always prevented) by using small tidal volumes of 6 mL/kg predicted body weight (PBW) and maintaining a plateau pressure of ≤30 cm H<sub>2</sub>O using a positive end-expiratory pressure (PEEP) strategy outlined in the table  (<a class="graphic graphic_table graphicRef87507" href="/z/d/graphic/87507.html" rel="external">table 2</a> and <a class="graphic graphic_table graphicRef87147" href="/z/d/graphic/87147.html" rel="external">table 3</a> and <a class="graphic graphic_table graphicRef57072" href="/z/d/graphic/57072.html" rel="external">table 4</a>). Some data suggest that a key ventilatory variable determining outcome is the driving pressure (driving pressure = plateau pressure - PEEP) [<a href="#rid36">36</a>], or the mechanical power delivered to the respiratory system [<a href="#rid37">37</a>]. Retrospective analysis of data from previous clinical trials suggest a combination of driving pressure and respiratory rate is somewhat more predictive of mortality than the more complex calculation of mechanical power. However, there are no prospective studies demonstrating whether ventilatory strategies should specifically aim to reduce either of these variables [<a href="#rid38">38</a>]. (See  <a class="medical medical_review" href="/z/d/html/1653.html" rel="external">"Acute respiratory distress syndrome: Ventilator management strategies for adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients without ARDS – In patients who do not have ARDS, we typically choose a protective ventilatory strategy similar to those with ARDS. This approach is based upon a few trials that have examined the effect of low tidal volume ventilation (LTVV) in this population. Other strategies targeted at atelectrauma (eg, high PEEP, open lung) have not been studied in patients without ARDS. Data to support LTVV in patients without ARDS are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1640.html" rel="external">"Overview of initiating invasive mechanical ventilation in adults in the intensive care unit", section on 'Tidal volume'</a>.)</p><p></p><p class="headingAnchor" id="H2898084025"><span class="h2">Second line strategies</span><span class="headingEndMark"> — </span>Other strategies that may be used when first line strategies fail include:</p><p class="bulletIndent1"><span class="glyph">●</span>High PEEP – Other ventilator strategies including open lung ventilation, monitoring driving pressure, and recruitment maneuvers which are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1653.html" rel="external">"Acute respiratory distress syndrome: Ventilator management strategies for adults"</a> and  <a class="medical medical_review" href="/z/d/html/1641.html" rel="external">"Acute respiratory distress syndrome: Fluid management, pharmacotherapy, and supportive care in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Paralysis – Neuromuscular blockers may be required in select circumstance when sedation has failed to correct conditions that confer a predisposition to VILI (eg, breath stacking) [<a href="#rid39">39</a>]. (See  <a class="medical medical_review" href="/z/d/html/1590.html" rel="external">"Neuromuscular blocking agents in critically ill patients: Use, agent selection, administration, and adverse effects"</a> and  <a class="medical medical_review" href="/z/d/html/1653.html" rel="external">"Acute respiratory distress syndrome: Ventilator management strategies for adults", section on 'Neuromuscular blockers'</a> and  <a class="medical medical_review" href="/z/d/html/1641.html" rel="external">"Acute respiratory distress syndrome: Fluid management, pharmacotherapy, and supportive care in adults", section on 'Paralysis (neuromuscular blockade)'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Prone positioning – Prone positioning has been shown to be effective in patients with severe ARDS and is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1630.html" rel="external">"Prone ventilation for adult patients with acute respiratory distress syndrome"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Extracorporeal membrane oxygenation (ECMO) – One strategy to decrease the physical stress induced by mechanical ventilation is to use ECMO or extracorporeal CO<sub>2</sub> removal (ECCO<sub>2</sub>R) to achieve gas exchange. However, although preliminary data suggest that ECMO may reduce mortality in patients with very severe ARDS [<a href="#rid40">40-42</a>], the use of ECMO or ECCO<sub>2</sub>R as an initial strategy to prevent VILI is unproven. (See  <a class="medical medical_review" href="/z/d/html/1618.html" rel="external">"Acute respiratory distress syndrome: Investigational or ineffective therapies in adults"</a> and  <a class="medical medical_review" href="/z/d/html/1625.html" rel="external">"Extracorporeal life support in adults in the intensive care unit: Overview"</a>.)</p><p></p><p class="headingAnchor" id="H1985893446"><span class="h1">INVESTIGATIONAL THERAPIES</span><span class="headingEndMark"> — </span>Several strategies have been used by experts without success, many of which are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1618.html" rel="external">"Acute respiratory distress syndrome: Investigational or ineffective therapies in adults"</a>.)</p><p>High frequency ventilation should be avoided as an initial strategy in most patients with acute respiratory distress syndrome. (See  <a class="medical medical_review" href="/z/d/html/1639.html" rel="external">"High-frequency ventilation in adults"</a>.)</p><p>The value of sedatives such as <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">ketamine</a> is unclear [<a href="#rid43">43</a>].</p><p class="headingAnchor" id="H11"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Ventilator-induced lung injury (VILI) is the process of acute lung injury that develops during mechanical ventilation. Ventilator-associated lung injury (VALI) is an iatrogenic disease that results from VILI and exists if a causative relationship cannot be proven. Self-induced lung injury is that due to excessive tidal volume due to spontaneous breaths. (See <a class="local">'Definitions (VILI, VALI, SILI)'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>VALI is commonly seen in patients receiving mechanical ventilation for acute respiratory distress syndrome (ARDS). However, VALI can occur in patients who are receiving mechanical ventilation for reasons other than ARDS. Other risk factors include large tidal volumes, blood product transfusions, acidemia, and restrictive lung disease. (See <a class="local">'Incidence and risk factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Alveolar overdistension, atelectrauma, and biotrauma are the principal mechanisms of VILI, although the relative contribution of each is unknown [<a href="#rid9">9</a>]. Alveolar injury results in high alveolar permeability, interstitial and alveolar edema, alveolar hemorrhage, hyaline membranes, loss of functional surfactant, and alveolar collapse (ie, ARDS) [<a href="#rid1">1,10,11</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>VALI is a clinical diagnosis based upon the clinical features of ARDS and the exclusion of alternative causes of respiratory deterioration and/or ARDS  (<a class="graphic graphic_table graphicRef58759" href="/z/d/graphic/58759.html" rel="external">table 1</a>) in mechanically ventilated patients. (See <a class="local">'Clinical features and diagnostic evaluation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The clinical presentation and diagnostic evaluation of patients with suspected VALI is similar to patients with progressive ARDS with the major difference being that the features develop while on mechanical ventilation itself. (See  <a class="medical medical_review" href="/z/d/html/1637.html" rel="external">"Acute respiratory distress syndrome: Clinical features, diagnosis, and complications in adults"</a> and <a class="local">'Clinical presentation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>New pulmonary infection and pulmonary edema are the most common etiologies that need to be distinguished from VALI. However, additional etiologies that occur as a consequence of being critically ill or mechanically ventilated also need to be considered (eg, sepsis, aspiration, barotrauma, auto-positive end-expiratory pressure [auto-PEEP], drug or transfusion reactions, venous, fat, air, or amniotic fluid embolism, intra-abdominal distension [ascites, ileus, or intra-abdominal hypertension], endotracheal tube displacement, lobar collapse, pulmonary effusion, and acute coronary syndromes). (See  <a class="medical medical_review" href="/z/d/html/1637.html" rel="external">"Acute respiratory distress syndrome: Clinical features, diagnosis, and complications in adults"</a> and <a class="local">'Clinical features and diagnostic evaluation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with VALI are managed in an identical fashion to patients with ARDS  (<a class="graphic graphic_table graphicRef87507" href="/z/d/graphic/87507.html" rel="external">table 2</a> and <a class="graphic graphic_table graphicRef87147" href="/z/d/graphic/87147.html" rel="external">table 3</a> and <a class="graphic graphic_table graphicRef57072" href="/z/d/graphic/57072.html" rel="external">table 4</a>). Therapies that target biotrauma have largely not been evaluated to date. (See <a class="local">'Prevention and management'</a> above and  <a class="medical medical_review" href="/z/d/html/1653.html" rel="external">"Acute respiratory distress syndrome: Ventilator management strategies for adults"</a> and  <a class="medical medical_review" href="/z/d/html/1641.html" rel="external">"Acute respiratory distress syndrome: Fluid management, pharmacotherapy, and supportive care in adults"</a> and <a class="local">'Investigational therapies'</a> above.)</p><p></p><p class="headingAnchor" id="H579645591"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Arthur S Slutsky, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">International consensus conferences in intensive care medicine: Ventilator-associated Lung Injury in ARDS. This official conference report was cosponsored by the American Thoracic Society, The European Society of Intensive Care Medicine, and The Societé de Réanimation de Langue Française, and was approved by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 1999; 160:2118.</a></li><li><a class="nounderline abstract_t">Brochard L, Slutsky A, Pesenti A. Mechanical Ventilation to Minimize Progression of Lung Injury in Acute Respiratory Failure. Am J Respir Crit Care Med 2017; 195:438.</a></li><li><a class="nounderline abstract_t">Gajic O, Dara SI, Mendez JL, et al. Ventilator-associated lung injury in patients without acute lung injury at the onset of mechanical ventilation. Crit Care Med 2004; 32:1817.</a></li><li><a class="nounderline abstract_t">Arcaroli JJ, Hokanson JE, Abraham E, et al. Extracellular superoxide dismutase haplotypes are associated with acute lung injury and mortality. Am J Respir Crit Care Med 2009; 179:105.</a></li><li><a class="nounderline abstract_t">Gao L, Grant A, Halder I, et al. Novel polymorphisms in the myosin light chain kinase gene confer risk for acute lung injury. Am J Respir Cell Mol Biol 2006; 34:487.</a></li><li><a class="nounderline abstract_t">Arcaroli J, Sankoff J, Liu N, et al. Association between urokinase haplotypes and outcome from infection-associated acute lung injury. Intensive Care Med 2008; 34:300.</a></li><li><a class="nounderline abstract_t">Hong SB, Huang Y, Moreno-Vinasco L, et al. Essential role of pre-B-cell colony enhancing factor in ventilator-induced lung injury. Am J Respir Crit Care Med 2008; 178:605.</a></li><li><a class="nounderline abstract_t">McClintock D, Zhuo H, Wickersham N, et al. Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury. Crit Care 2008; 12:R41.</a></li><li><a class="nounderline abstract_t">Slutsky AS, Ranieri VM. Ventilator-induced lung injury. N Engl J Med 2013; 369:2126.</a></li><li><a class="nounderline abstract_t">Rouby JJ, Brochard L. Tidal recruitment and overinflation in acute respiratory distress syndrome: yin and yang. Am J Respir Crit Care Med 2007; 175:104.</a></li><li><a class="nounderline abstract_t">Hughes KT, Beasley MB. Pulmonary Manifestations of Acute Lung Injury: More Than Just Diffuse Alveolar Damage. Arch Pathol Lab Med 2017; 141:916.</a></li><li><a class="nounderline abstract_t">Caironi P, Cressoni M, Chiumello D, et al. Lung opening and closing during ventilation of acute respiratory distress syndrome. Am J Respir Crit Care Med 2010; 181:578.</a></li><li><a class="nounderline abstract_t">Dreyfuss D, Soler P, Saumon G. Mechanical ventilation-induced pulmonary edema. Interaction with previous lung alterations. Am J Respir Crit Care Med 1995; 151:1568.</a></li><li><a class="nounderline abstract_t">Hernandez LA, Peevy KJ, Moise AA, Parker JC. Chest wall restriction limits high airway pressure-induced lung injury in young rabbits. J Appl Physiol (1985) 1989; 66:2364.</a></li><li><a class="nounderline abstract_t">Gattinoni L, Pesenti A. The concept of "baby lung". Intensive Care Med 2005; 31:776.</a></li><li><a class="nounderline abstract_t">Gattinoni L, Protti A, Caironi P, Carlesso E. Ventilator-induced lung injury: the anatomical and physiological framework. Crit Care Med 2010; 38:S539.</a></li><li><a class="nounderline abstract_t">Sugiura M, McCulloch PR, Wren S, et al. Ventilator pattern influences neutrophil influx and activation in atelectasis-prone rabbit lung. J Appl Physiol (1985) 1994; 77:1355.</a></li><li><a class="nounderline abstract_t">Muscedere JG, Mullen JB, Gan K, Slutsky AS. Tidal ventilation at low airway pressures can augment lung injury. Am J Respir Crit Care Med 1994; 149:1327.</a></li><li><a class="nounderline abstract_t">Coudroy R, Lu C, Chen L, et al. Mechanism of airway closure in acute respiratory distress syndrome: a possible role of surfactant depletion. Intensive Care Med 2019; 45:290.</a></li><li><a class="nounderline abstract_t">Tremblay LN, Slutsky AS. Ventilator-induced lung injury: from the bench to the bedside. Intensive Care Med 2006; 32:24.</a></li><li><a class="nounderline abstract_t">Tremblay LN, Slutsky AS. Ventilator-induced injury: from barotrauma to biotrauma. Proc Assoc Am Physicians 1998; 110:482.</a></li><li><a class="nounderline abstract_t">Imai Y, Kawano T, Miyasaka K, et al. Inflammatory chemical mediators during conventional ventilation and during high frequency oscillatory ventilation. Am J Respir Crit Care Med 1994; 150:1550.</a></li><li><a class="nounderline abstract_t">Pugin J, Dunn I, Jolliet P, et al. Activation of human macrophages by mechanical ventilation in vitro. Am J Physiol 1998; 275:L1040.</a></li><li><a class="nounderline abstract_t">Tremblay L, Valenza F, Ribeiro SP, et al. Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model. J Clin Invest 1997; 99:944.</a></li><li><a class="nounderline abstract_t">von Bethmann AN, Brasch F, Nüsing R, et al. Hyperventilation induces release of cytokines from perfused mouse lung. Am J Respir Crit Care Med 1998; 157:263.</a></li><li><a class="nounderline abstract_t">Held HD, Boettcher S, Hamann L, Uhlig S. Ventilation-induced chemokine and cytokine release is associated with activation of nuclear factor-kappaB and is blocked by steroids. Am J Respir Crit Care Med 2001; 163:711.</a></li><li><a class="nounderline abstract_t">Acute Respiratory Distress Syndrome Network, Brower RG, Matthay MA, et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342:1301.</a></li><li><a class="nounderline abstract_t">Ranieri VM, Suter PM, Tortorella C, et al. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA 1999; 282:54.</a></li><li><a class="nounderline abstract_t">Stüber F, Wrigge H, Schroeder S, et al. Kinetic and reversibility of mechanical ventilation-associated pulmonary and systemic inflammatory response in patients with acute lung injury. Intensive Care Med 2002; 28:834.</a></li><li><a class="nounderline abstract_t">Parsons PE, Eisner MD, Thompson BT, et al. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med 2005; 33:1.</a></li><li><a class="nounderline abstract_t">Parsons PE, Matthay MA, Ware LB, et al. Elevated plasma levels of soluble TNF receptors are associated with morbidity and mortality in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol 2005; 288:L426.</a></li><li><a class="nounderline abstract_t">Cabrera-Benítez NE, Parotto M, Post M, et al. Mechanical stress induces lung fibrosis by epithelial-mesenchymal transition. Crit Care Med 2012; 40:510.</a></li><li><a class="nounderline abstract_t">Borrelli E, Roux-Lombard P, Grau GE, et al. Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit Care Med 1996; 24:392.</a></li><li><a class="nounderline abstract_t">Law MM, Cryer HG, Abraham E. Elevated levels of soluble ICAM-1 correlate with the development of multiple organ failure in severely injured trauma patients. J Trauma 1994; 37:100.</a></li><li><a class="nounderline abstract_t">Plötz FB, Slutsky AS, van Vught AJ, Heijnen CJ. Ventilator-induced lung injury and multiple system organ failure: a critical review of facts and hypotheses. Intensive Care Med 2004; 30:1865.</a></li><li><a class="nounderline abstract_t">Amato MB, Meade MO, Slutsky AS, et al. Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med 2015; 372:747.</a></li><li><a class="nounderline abstract_t">Tonetti T, Vasques F, Rapetti F, et al. Driving pressure and mechanical power: new targets for VILI prevention. Ann Transl Med 2017; 5:286.</a></li><li><a class="nounderline abstract_t">Costa ELV, Slutsky AS, Brochard LJ, et al. Ventilatory Variables and Mechanical Power in Patients with Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med 2021; 204:303.</a></li><li><a class="nounderline abstract_t">Slutsky AS, Villar J. Early Paralytic Agents for ARDS? Yes, No, and Sometimes. N Engl J Med 2019; 380:2061.</a></li><li><a class="nounderline abstract_t">Combes A, Hajage D, Capellier G, et al. Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome. N Engl J Med 2018; 378:1965.</a></li><li><a class="nounderline abstract_t">Harrington D, Drazen JM. Learning from a Trial Stopped by a Data and Safety Monitoring Board. N Engl J Med 2018; 378:2031.</a></li><li><a class="nounderline abstract_t">Goligher EC, Tomlinson G, Hajage D, et al. Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome and Posterior Probability of Mortality Benefit in a Post Hoc Bayesian Analysis of a Randomized Clinical Trial. JAMA 2018; 320:2251.</a></li><li><a class="nounderline abstract_t">Wang WF, Liu S, Xu B. A study of the protective effect and mechanism of ketamine on acute lung injury induced by mechanical ventilation. Eur Rev Med Pharmacol Sci 2017; 21:1362.</a></li></ol></div><div id="topicVersionRevision">Topic 1598 Version 26.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10588637" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : International consensus conferences in intensive care medicine: Ventilator-associated Lung Injury in ARDS. This official conference report was cosponsored by the American Thoracic Society, The European Society of Intensive Care Medicine, and The Societéde Réanimation de Langue Française, and was approved by the ATS Board of Directors, July 1999.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27626833" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Mechanical Ventilation to Minimize Progression of Lung Injury in Acute Respiratory Failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15343007" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Ventilator-associated lung injury in patients without acute lung injury at the onset of mechanical ventilation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18948423" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Extracellular superoxide dismutase haplotypes are associated with acute lung injury and mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16399953" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Novel polymorphisms in the myosin light chain kinase gene confer risk for acute lung injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17994220" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Association between urokinase haplotypes and outcome from infection-associated acute lung injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18658108" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Essential role of pre-B-cell colony enhancing factor in ventilator-induced lung injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18358078" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24283226" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Ventilator-induced lung injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17200505" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Tidal recruitment and overinflation in acute respiratory distress syndrome: yin and yang.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27652982" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Pulmonary Manifestations of Acute Lung Injury: More Than Just Diffuse Alveolar Damage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19910610" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Lung opening and closing during ventilation of acute respiratory distress syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7735616" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Mechanical ventilation-induced pulmonary edema. Interaction with previous lung alterations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2745302" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Chest wall restriction limits high airway pressure-induced lung injury in young rabbits.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15812622" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : The concept of "baby lung".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21164395" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Ventilator-induced lung injury: the anatomical and physiological framework.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7836140" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Ventilator pattern influences neutrophil influx and activation in atelectasis-prone rabbit lung.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8173774" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Tidal ventilation at low airway pressures can augment lung injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30560279" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Mechanism of airway closure in acute respiratory distress syndrome: a possible role of surfactant depletion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16231069" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Ventilator-induced lung injury: from the bench to the bedside.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9824530" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Ventilator-induced injury: from barotrauma to biotrauma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7952613" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Inflammatory chemical mediators during conventional ventilation and during high frequency oscillatory ventilation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9843840" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Activation of human macrophages by mechanical ventilation in vitro.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9062352" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9445308" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Hyperventilation induces release of cytokines from perfused mouse lung.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11254529" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Ventilation-induced chemokine and cytokine release is associated with activation of nuclear factor-kappaB and is blocked by steroids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10793162" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10404912" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12122519" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Kinetic and reversibility of mechanical ventilation-associated pulmonary and systemic inflammatory response in patients with acute lung injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15644641" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15516488" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Elevated plasma levels of soluble TNF receptors are associated with morbidity and mortality in patients with acute lung injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21926573" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Mechanical stress induces lung fibrosis by epithelial-mesenchymal transition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8625625" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7913140" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Elevated levels of soluble ICAM-1 correlate with the development of multiple organ failure in severely injured trauma patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15221129" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Ventilator-induced lung injury and multiple system organ failure: a critical review of facts and hypotheses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25693014" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Driving pressure and survival in the acute respiratory distress syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28828361" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Driving pressure and mechanical power: new targets for VILI prevention.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33784486" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Ventilatory Variables and Mechanical Power in Patients with Acute Respiratory Distress Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31112382" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Early Paralytic Agents for ARDS? Yes, No, and Sometimes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29791822" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29791830" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Learning from a Trial Stopped by a Data and Safety Monitoring Board.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30347031" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome and Posterior Probability of Mortality Benefit in a Post Hoc Bayesian Analysis of a Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28387889" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : A study of the protective effect and mechanism of ketamine on acute lung injury induced by mechanical ventilation.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
